Do not buy Incyte Corporation stock before seeing this video!📈 (INCY Stock Analysis)

preview_player
Показать описание
🔥 Free Telegram Channel:

💵Best place to buy and hold PRE IPO:

❤️ YouTube paid subscription:

💸 Patreon paid subscription:

I am helping people to buy PRE IPO. Just write to me via email: (channel page → about) or Instagram: @stelmakdv

I use two brokers to trade stocks:
They are both SIPC protected up to $500,000

I read all comments, feel free to ask questions and publish your thoughts about the stock market. Sometimes the comments are extremely helpful!

I speak too slow? Change the playback speed to 1.5-2.0

I recommend you watch these videos:
🥇 Side Hustle Ideas:

🥈 China 2021-2025 Plan:

🥉 Venture investments:

🏅 Investing vs Speculating:

🏅 Inflation rate and interest rate:

☢DISCLAIMER: I recommend you always do your research. Never invest more than 5% of your portfolio in one stock. I am not 100% right all the time. You could lose money following my advice. Some links may be affiliated. Video content could contain paid promotions.☢
Рекомендации по теме
Комментарии
Автор

I'm happy to have found your channel!

MrGreyKa
Автор

WILMINGTON, Del., July 23, 2021--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, for the treatment of adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy.
The complete response letter states that the FDA cannot approve the application in its present form.

DenisStelmak
Автор

Денис, давай пари, у Инсайт или/& Морфосис будет байаут. Слышком хорошая и дёшевая кампания. Что думаеш?

mikedaniels